Delivery Order SPE2DB22D3004-SPE2DB23FRK48
Award Date 9/22/23
Potential Completion Date 9/25/23
Potential Value $21K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $20,398.62 firm fixed price delivery order to Amerisourcebergen Drug Corporation for RINVOQ ER 45 MG tablets. The order is for 28S of the medication and will be fulfilled from Amerisourcebergen's facility located in Conshohocken, Pennsylvania by August 9, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order for RINVOQ, a prescription medication used to treat rheumatoid arthritis, supports the Defense...
- The Defense Logistics Agency awarded a $56,931.76 firm fixed price delivery order to Amerisourcebergen Drug Corporation for RINVOQ ER 15 MG tablets. The order is for 30 units of the medication to be delivered to Amerisourcebergen's facility in Conshohocken, Pennsylvania by August 9, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order for Rinvoq, an FDA-approved treatment for rheumatoid arthritis, supports the Defense Logistics Agency's...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $7,818 to Amerisourcebergen Drug Corporation for RINVOQ ER 45 MG tablets. The order is to provide 28,500 tablets to a Defense Logistics Agency facility located in Conshohocken, Pennsylvania, with performance required between September 15-18, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense globally, this order for RINVOQ, an FDA-approved treatment for...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $40,391.94 to Amerisourcebergen Drug Corporation for RINVOQ ER 45 MG tablets. The order is to provide 28,500 tablets to a facility located in Conshohocken, Pennsylvania, with performance required between July 14-17, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense globally, this order for RINVOQ, a prescription medication used to treat rheumatoid arthritis, will...
- The Defense Logistics Agency awarded a delivery order under an undisclosed contract vehicle to Amerisourcebergen Drug Corporation for $10,804.42 to supply 4561326514 RINVOQ ER 45 MG tablets. Performance will take place in Conshohocken, Pennsylvania from June 23 to June 26, 2023. The firm-fixed-price order is for the delivery of RINVOQ, an oral Janus kinase inhibitor medication used to treat rheumatoid arthritis. As a major provider of pharmaceuticals and medical supplies to the U.S. Department...
- The Defense Logistics Agency awarded a delivery order valued at $54,355.68 to AmerisourceBergen Drug Corp for RINVOQ ER 15 MG tablets in quantities of 30 units, with an ultimate completion date of June 23, 2025. This firm fixed-price delivery order, which was competitively awarded with no set-aside designation, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. RINVOQ is a prescription medication used in the treatment of rheumatoid arthritis and...
- The Defense Logistics Agency awarded a $52,829.95 firm fixed price delivery order to Amerisourcebergen Drug Corporation for RINVOQ ER 15 MG tablets. The order is for 30 units of the medication to be delivered to a location in Conshohocken, Pennsylvania by September 15, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics network and supply chain, and this order for RINVOQ tablets is likely to support the medical needs of service members. Amerisourcebergen...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at $17,063.21 to Amerisourcebergen Drug Corporation for RINVOQ ER 45 MG tablets. The place of performance is Conshohocken, Pennsylvania. The period of performance is from August 8, 2023 through August 9, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order for Rinvoq, an oral JAK inhibitor used to treat rheumatoid arthritis, will support the...
- The Defense Logistics Agency awarded a $10,870.71 firm fixed price delivery order to Amerisourcebergen Drug Corporation for RINVOQ ER 15 MG tablets. The order is for 30 units of the medication to be delivered to a location in Conshohocken, Pennsylvania by July 31, 2023. The prime contractor, Amerisourcebergen Drug Corporation, will fulfill the order from its Corporate Office Division. As the Defense Logistics Agency is the logistics combat support agency for the Department of Defense, this order...
- The Defense Logistics Agency awarded a delivery order valued at $12.3K to AmerisourceBergen Drug Corp for RINVOQ ER 45 mg tablets (28-count units) on August 13, 2025, with completion targeted for August 14, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. RINVOQ is a prescription medication used to treat rheumatoid arthritis and other inflammatory...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB23FRK48Delivery Order
The Defense Logistics Agency awarded a $20,889.30 firm fixed price delivery order to Amerisourcebergen Drug Corporation for RINVOQ ER 15 MG tablets. The order is for 30 units of the medication and will be fulfilled by Amerisourcebergen from its facility in Conshohocken, Pennsylvania by September 25, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order for RINVOQ, a prescription medication used to treat rheumatoid arthritis, supports the Defense Logistics Agency's mission to provide critical logistics capabilities and enable worldwide global mobility.
Generated 12/22/23, 10:14 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.9k | 9/22/23 |